Additionally, EVs released from breast cancer cells can activate signalling pathways like PI3K/Akt, Akt2, FAK, and ERK1/2 in non-tumorigenic breast cells, enhancing their invasiveness and migration abilities [127]. Here, AKT1 is linked to breast carcinoma.